Advertisement
Research Updates

Treatment

  • The Ins and Outs of Tumor Testing

    In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.

    by Kate Yandell

  • Non–Small Cell Lung Cancer Takes Center Stage

    A trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non-small cell lung cancer treatment.

    by Brad Jones

  • A New Type of Drug Approval

    At the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.

    by Kate Yandell

  • Artificial Intelligence Characterizes Cancer

    At the AACR Annual Meeting 2018, researchers at Google compared the speed and accuracy of human pathologists and computer algorithms in diagnosing and grading cancer.

    by Kevin McLaughlin

  • Pembrolizumab Shows Further Promise for Melanoma

    In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.

    by Brad Jones

  • A Better Way to Screen for Lynch Syndrome?

    Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.

    by Cheryl Platzman Weinstock

  • Forward Look

    Treating Early-Stage Lung Cancer

    Efforts are underway to define role of high-dose radiation.

    by Stephen Ornes

  • Searching Blood for Cancer Clues

    Researchers are developing blood tests that help track and identify molecular changes in tumors. But many hurdles remain before these “liquid biopsies” become standard.

    by Stephen Ornes

  • Liver Cancer on the Rise

    Liver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.

    by Sue Rochman

  • From the Editor-in-Chief

    DNA Profiling Moves From Forensics to Diagnostics

    DNA profiling technologies are providing new ways to detect and monitor cancer.

    by William G. Nelson, MD, PhD